Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anika Therapeutics Inc ANIK

Anika Therapeutics, Inc. is a joint preservation company focused on developing, manufacturing, and commercializing products based on hyaluronic acid (HA) technology platform. The OA Pain Management product family consists of Monovisc and Orthovisc that provides pain relief from osteoarthritis conditions and Cingal consisting of its cross-linked HA material combined with a fast-acting steroid... see more

Recent & Breaking News (NDAQ:ANIK)

Anika Therapeutics Announces Strategic Collaboration with the Institute for Applied Life Sciences (IALS) at the University of Massachusetts Amherst

Business Wire June 17, 2015

Anika Therapeutics to Present at Jefferies 2015 Global Healthcare Conference on June 4

Business Wire May 21, 2015

Anika Therapeutics Announces Presentation of Seven Abstracts at 12th Annual World Congress of the International Cartilage Repair Society

Business Wire April 28, 2015

Anika Therapeutics Reports First-Quarter 2015 Financial Results

Business Wire April 28, 2015

Anika Therapeutics Reports on Cingal® 13-01 Study Clinical Trial Top Line Data and Announces the Completion of Cingal 13-02 Study's Patient Enrollment

Business Wire April 17, 2015

Anika Therapeutics Announces Date of First-Quarter 2015 Financial Results Conference Call

Business Wire April 15, 2015

Hyalomatrix® Receives CMS Reimbursement Coverage in 11 States

Business Wire April 10, 2015

Anika Therapeutics Files IDE Application with U.S. FDA for Hyalofast®

Business Wire April 8, 2015

Anika Therapeutics to Present at Canaccord Genuity Musculoskeletal Conference March 24

Business Wire March 17, 2015

Anika Therapeutics Reports Fourth-Quarter and Full-Year 2014 Financial Results

Business Wire February 25, 2015

Anika Therapeutics Appoints Dr. Glenn Larsen to its Board of Directors

Business Wire February 19, 2015

Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2014 Financial Results Conference Call

Business Wire February 12, 2015

Anika Therapeutics Announces Regulatory Submissions with U.S. FDA and European Regulatory Authorities for Cingal®

Business Wire February 11, 2015

Center for Medicare & Medicaid Services Announces That a Unique Reimbursement Code is Assigned to Anika's MONOVISC® Product

Business Wire November 10, 2014

Anika Therapeutics Reports Third-Quarter 2014 Financial Results

Business Wire October 29, 2014

Anika Therapeutics Announces Date of Third-Quarter 2014 Financial Results Conference Call

Business Wire October 16, 2014

Anika Therapeutics to Present at Canaccord Genuity 34th Annual Growth Conference

Business Wire August 4, 2014

Anika Therapeutics Reports Second-Quarter 2014 Financial Results

Business Wire July 30, 2014

Anika Therapeutics Announces U.S. Commercialization Partnership for Hyalomatrix® with Wound Care Leader Medline Industries, Inc.

Business Wire July 30, 2014

Anika Therapeutics Announces Date of Second-Quarter 2014 Financial Results Conference Call

Business Wire July 15, 2014